Caplin Point Lab
Company Overview - January 14, 2025
Caplin Point Lab is a notable player in the Pharmaceuticals - Indian - Formulations industry, listed on both the BSE (Code: 524742) and NSE (Code: CAPLIPOINT). As of the January 14, 2025, the company holds a market capitalization of INR 16360.37 crores, placing it among the top-performing companies in its sector.
With a current stock price of INR 2152.35, Caplin Point Lab has demonstrated a 67.92% return over the last year. Recent performance indicates fluctuations, with a 7.31% change in the past week and a 6.46% change over the last month. The company's all-time high stands at INR 2195.00, while its lowest-ever price was INR 1.05.
In terms of sales, Caplin Point Lab reported a revenue of INR 1830.78 crores, solidifying its position in the market. The average trading volume over the past month has been 137255 shares, with a more recent weekly average of 229186.
With the stock trading above its 50-day moving average of INR 1942.44, the company's technical indicators like MACD (33.13) signal positive trends.
Company Data
| Name | Caplin Point Lab |
|---|---|
| BSE Code | 524742 |
| NSE Code | CAPLIPOINT |
| Industry | Pharmaceuticals - Indian - Formulations |
| Current Price | 2152.35 |
| Market Capitalization | 16360.37 |
| Sales | 1830.78 |
| Return over 3months | 10.62 |
| Return over 6months | 63.32 |
| Volume 1month average | 137255 |
| Volume 1week average | 229186 |
| Volume | 265511 |
| High price | 2195.00 |
| Low price | 1178.00 |
| High price all time | 2195.00 |
| Low price all time | 1.05 |
| Return over 1day | 2.14 |
| Return over 1week | 7.31 |
| Return over 1month | 6.46 |
| Return over 1year | 67.92 |
| Return over 3years | 41.20 |
| Return over 5years | 46.34 |
| Volume 1year average | 222127 |
| DMA 50 | 1942.44 |
| DMA 200 | 1646.91 |
| DMA 50 previous day | 1935.71 |
| DMA 200 previous day | 1642.28 |
| MACD | 33.13 |
| MACD Signal | 23.57 |